SMAD7 and glioma: Furthermore, our findings show that melatonin deregulates Smad7 expression to suppress TGFβ/Smad-mediated increase in CCL20 transcript levels and CCL20-induced EMT occurrence, suggesting potential anti-EMT therapeutic strategy of melatonin to overcome malignant transformation in gliomas.